GeneOne Life Science

011000 · KOSPI · Health Care · SMALL CAP

Updated terms.

GeneOne Life Science updated the disclosed terms of an acquisition, now worth US$2M.

M&A([Amended] Decision to acquire shares/equity in another company)· FILED 2026-05-15· RCEPT 20260515801983

US$2MDeal value
2.5%vs. company assets

Converted at 1 USD ≈ ₩1,493.34 (filing-date rate, 2026-05-14 close)

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-06-15) →

What happened

GeneOne Life Science updated the disclosed terms of an acquisition, now worth US$2M.

For context, this deal is worth about 2.5% of the company's own total assets.

TargetDisclosed
Deal valueUS$2M
vs. company assets2.5%
Filed2026-05-15, [Amended] Decision to acquire shares/equity in another company
SourceDART rcept 20260515801983 → open original filing

Versions of this filing

  1. 2026-04-14Original
  2. 2026-04-30Amendment 1
  3. 2026-05-15Amendment 2 (this page)
  4. 2026-06-15Amendment 3

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-15 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.